Negative results from the latest meta-analysis, which covered 21 randomized clinical studies of >83,000 participants
Scientific uncertainty persists about the relationship between vitamin D levels and the risk for cardiovascular disease (CVD). A U.S. survey in 2012 found increasing use, with about 19% of respondents reported taking vitamin D, excluding multivitamins. To learn more, investigators performed a meta-analysis of all randomized, controlled trials that evaluated the efficacy of vitamin D supplementation for cardiovascular prevention.
The authors identified 21 trials with 83,291 participants (mean age, 65). The various trials used different supplements, including cholecalciferol and vitamin D analogues. CVD was a primary outcome in only four studies.
In follow-ups ranging from 1 to 12 years, vitamin D supplementation showed no significant effect on…
Reviewing Author
DisclosuresConsultant/Advisory BoardUnited Healthcare; Element Science; Eyedentifeye, F-Prime
EquityHugo Health; Refactor Health; Element Science
Grant/Research SupportPfizer; Agency for Healthcare Research and Quality; Janssen Research and Development, National Institute of Biomedical Imaging and Engineering; National Heart, Lung, and Blood Institute; Centers for Disease Control and Prevention; National Cancer Institute; American Heart Association
DisclosuresConsultant/Advisory BoardUnited Healthcare; Element Science; Eyedentifeye, F-Prime
EquityHugo Health; Refactor Health; Element Science
Grant/Research SupportPfizer; Agency for Healthcare Research and Quality; Janssen Research and Development, National Institute of Biomedical Imaging and Engineering; National Heart, Lung, and Blood Institute; Centers for Disease Control and Prevention; National Cancer Institute; American Heart Association